FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2023. Module: SNOMED CT core module

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym Active Entire term case insensitive SNOMED CT core module
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive SNOMED CT core module
    3442105014 1 en Synonym Active Entire term case insensitive SNOMED CT core module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Existential restriction modifier
    1 Is a Number false Inferred relationship Existential restriction modifier

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Cyproterone 50mg tablets (Stragen UK Ltd) 168 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Cyproterone 100mg tablets (Stragen UK Ltd) 84 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Cyproterone 100mg tablets (Stragen UK Ltd) 84 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength numerator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 10 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Erythromycin 1g powder for solution for infusion vials (Stragen UK Ltd) 10 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 84 tablet 3 x 28 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 84 tablet 3 x 28 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 168 tablet 6 x 28 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Moonia 75microgram tablets (Kent Pharma (UK) Ltd) 168 tablet 6 x 28 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 5mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 10mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 15mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) 28 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Aripiprazole 30mg tablets (Rivopharm (UK) Ltd) 28 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 5mg tablets (Rivopharm (UK) Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 10mg tablets (Rivopharm (UK) Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 8 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Vardenafil 20mg tablets (Rivopharm (UK) Ltd) 8 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Memantine 10mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Memantine 10mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Levocetirizine 5mg tablets (Bristol Laboratories Ltd) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Letrozole 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 2.5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Olanzapine 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 10mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 20mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Tadalafil 5mg tablets (Sun Pharmaceutical Industries Europe B.V.) Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Levocetirizine 5mg tablets 60 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Levocetirizine 5mg tablets 60 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 40mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Atorvastatin 80mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Methyldopa 125mg tablets (Bristol Laboratories Ltd) 56 tablet 4 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Prednisolone 2.5mg gastro-resistant tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Voriconazole 200mg powder for solution for infusion vials (Fresenius Kabi Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 4 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 4 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 8 tablet 2 x 4 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Sildenafil 100mg tablets (Bristol Laboratories Ltd) 8 tablet 2 x 4 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 10 tablet Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Ciprofloxacin 250mg tablets (Nexcape Pharmaceuticals Ltd) 100 tablet 10 x 10 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) 1 vial Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Zessly 100mg powder for concentrate for solution for infusion vials (Sandoz Ltd) 1 vial Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    NP Thyroid 60mg (1 grain) tablets (Imported (United States)) 100 tablet Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 2
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Metoclopramide 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier
    Memantine 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has presentation strength denominator value False 1 Inferred relationship Existential restriction modifier 1
    Memantine 10mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Count of base of active ingredient False 1 Inferred relationship Existential restriction modifier

    Start Previous Page 324 of 342 Next End


    This concept is not in any reference sets

    Back to Start